Symbol
CMMB on Nasdaq
Investment type
Equity / Ordinary Shares / American Depositary Shares
Latest Disclosed Ownership
970K shares
Security Ownership
4.8%

ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP ownership in Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB)

2025-06-23 - ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 970K shares of Chemomab Therapeutics Ltd. Ordinary Shares / American Depositary Shares (CMMB). This represents 4.8% percent ownership of the company.